- While misinformation has been the object of great attention in politics, medical misinformation might have an even greater body count.
- False medical information can also lead to patients’ experiencing greater side effects through the “nocebo effect.”
- Cancer is another big target for pushers of medical misinformation — many of whom are making money off alternative therapies.
- Fake news represents a huge opportunity for pharma to lead the conversation.
- The life sciences industry’s commitment to digital transformation is increasing, but few organizations are digitally maturing.
- Digital transformation is no longer a buzzword, but a strategic imperative for life sciences companies.
- While first movers would likely gain a competitive advantage, all of today’s companies risk falling behind their competitors in delivering across all elements of the value chain if their strategies are limited to a few pilots and experiments.
- Life sciences companies have been fast followers in adopting new technologies, but waiting too long to commit could leave some companies with portions of their value chains disrupted in an ever more price-conscious segment.
- Pharma companies need to recruit Millenials, but company culture is a barrier.
- Allowing employees to wear jean is not a way to attract new talent.
- The pharma organization must go through a transformation in order to better compete.
- Patient centricity is not as important as shareholders and Wall Street.
- CEO’s are often compensated on financial metrics and focus on the balance sheet.
- Patient centricity starts with an organizations people but Millennials are avoiding careers in pharma because of the culture.
At first it seems like good news. Retail drug spending slowed substantially to 0.4 percent, but hidden in another category, Physician and Clinical Services, spending increased. Drugs which are infused in a clinical setting are included in this category, such as cancer drugs and drugs for MS.Continue reading
- A study showing that one in four insulin-treated patients surveyed at an urban US diabetes center were found to be cutting back on insulin use because of cost has been published.
- The survey results also reveal that cost-related insulin underuse was associated with worse glycemic control and that more than a third of patients did not discuss the insulin underuse with their clinicians.
- Of those who completed the survey, 25.5% (51) reported cost-related insulin underuse.
Eight in ten Americans say that caregiving is the “new normal” in American families.
Forty million Americans are currently caregivers—almost as many as the number of Americans holding student debt.
These caregivers are providing assistance to nearly 50 million adults receiving care. Half became caregivers in the past year.